Aura Biosciences, Inc. AURA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.23M-6.1% | $6.63M-6.9% | $7.12M-5.9% | $7.56M-9.3% | $8.34M-11.6% | ||
| $94.92M+5.1% | $90.3M-0.5% | $90.74M+6.0% | $85.6M+7.5% | $79.59M+8.6% | ||
| $23.71M+5.4% | $22.49M-0.6% | $22.62M-2.0% | $23.09M-0.7% | $23.24M+1.9% | ||
| $118.62M+5.2% | $112.79M-0.5% | $113.36M+4.3% | $108.69M+5.7% | $102.84M+7.0% | ||
| -$118.62M-5.2% | -$112.79M+0.5% | -$113.36M-4.3% | -$108.69M-5.7% | -$102.84M-7.0% | ||
| $6.33M-5.6% | $6.71M-4.3% | $7.01M-5.8% | $7.44M-9.5% | $8.23M-11.6% | ||
| -$112.29M-5.9% | -$106.08M+0.3% | -$106.35M-5.0% | -$101.25M-7.0% | -$94.61M-9.0% | ||
| $100K-6.5% | $107K-7.8% | $116K-12.8% | $133K+56.5% | $85K-24.8% | ||
| -$112.39M-5.8% | -$106.19M+0.3% | -$106.47M-5.0% | -$101.38M-7.1% | -$94.7M-8.9% | ||
| -$1.74+2.8% | -$1.79+7.7% | -$1.94+1.0% | -$1.96-3.2% | -$1.90-8.6% | ||
| -$1.74+2.8% | -$1.79+7.7% | -$1.94+1.0% | -$1.96-3.2% | -$1.90-8.6% | ||
| 251.7M+7.4% | 234.4M+4.8% | 223.7M+7.8% | 207.5M+4.3% | 199M+0.3% | ||
| 251.7M+7.4% | 234.4M+4.8% | 223.7M+7.8% | 207.5M+4.3% | 199M+0.3% | ||
| -$112.71M-5.8% | -$106.56M+0.4% | -$107M-5.8% | -$101.17M-6.9% | -$94.61M-8.5% | ||
| $6.23M-6.1% | $6.63M-6.9% | $7.12M-5.9% | $7.56M-9.3% | $8.34M-11.6% | ||
| -$120K+33.0% | -$179K+64.7% | -$507K-324% | $226K+100% | $113K+142% | ||
| -$192K-3.2% | -$186K-583% | -$27.25K-75.8% | -$15.5K+37.4% | -$24.75K-395% | ||
| $102K+34.2% | $76K+169% | -$110K+9.8% | -$122K-8.9% | -$112K+6.7% | ||
| -$118.62M-5.2% | -$112.79M+0.5% | -$113.36M-4.3% | -$108.69M-5.7% | -$102.84M-7.0% | ||
| -$117.48M-5.2% | -$111.63M+0.5% | -$112.18M-4.3% | -$107.51M-5.8% | -$101.65M-7.1% | ||
| -$117.48M-5.2% | -$111.63M+0.5% | -$112.18M-4.3% | -$107.51M-5.8% | -$101.65M-7.1% | ||
| -$118.62M-5.2% | -$112.79M+0.5% | -$113.36M-4.3% | -$108.69M-5.7% | -$102.84M-7.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Aura Biosciences, Inc. profitable?
- Aura Biosciences, Inc. is not currently profitable: it reported a net loss of $112.4M over the trailing twelve months.
- What is Aura Biosciences, Inc.'s earnings per share?
- Aura Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-1.74.
- Where does Aura Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.